Somatuline Autogel · DIN 02283395 · 60 mg/Syr · extended release pre-filled syringe Pk
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Somatuline Autogel · DIN 02283395
Manufacturer: Ipsen Limited; listing date 2008-11-04
Health Canada: Marketed since 2022-02-16 · brand SOMATULINE AUTOGEL · ATC H01CB03 LANREOTIDE · form Solution (extended-release) · route Subcutaneous · ingredients LANREOTIDE (LANREOTIDE ACETATE) 60 MG/SYR · company Ipsen biopharmaceuticals canada inc · schedule Prescription
Ministry pays: $760.0056 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02283395)
Source record
DIN 02283395: Somatuline Autogel
Raw flags: sec3=Y
Item: 920000582; group id 926; item number 2204; lccId None; manufacturer id IPS
Source form: ER Pref Syr Pk; strength: 60mg/Syr
Recorded listing: General benefit
Source prices (unrounded): $1450.9198; ministry $760.0056
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02283395
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=76900
Interchangeable products
Mytolac · DIN 02555867 · $760.0056
Shortage status: not checked (no credentials)